Sanara MedTech Inc. (SMTI) income statement
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30147% above fair value
$32.55−0.12 (-0.37%)
Close on Nov 20, 2026Market cap $299.07MP/E –Yield –
Sanara MedTech Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 93.0%
- Operating margin
- 7.7%
- Net margin
- -29.2%
- Return on equity, FY2025
- -165.7%
Financial strength
- Current ratio
- 2.58
- Debt to equity
- 5.85
- Debt to assets
- 67.2%
- Cash to current liabilities
- 123.4%
Valuation
- P/E ratio
- –
- Price to sales
- 2.72
- Price to book
- 37.65
- Dividend yield
- –
See a number that looks wrong?